Filing Details

Accession Number:
0001628280-23-008048
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-15 14:15:49
Reporting Period:
2023-03-13
Accepted Time:
2023-03-15 14:15:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
727207 Accelerate Diagnostics Inc AXDX Laboratory Analytical Instruments (3826) 841072256
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1556290 Steven Reichling C/O Accelerate Diagnostics, Inc.
3950 S. Country Club Road, Suite 470
Tucson AZ 85714
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-13 9,438 $0.00 147,078 No 4 M Direct
Common Stock Disposition 2023-03-13 4,708 $0.49 142,370 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Restricted Stock Units Disposition 2023-03-13 9,438 $0.00 9,438 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 113,265 restricted stock units, which vests in equal amounts every month for 12 months.
  2. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.